Antipsychotic drugs block phencyclidine receptor-mediated neurotoxicity

Biological Psychiatry

Volumn 34, Issue 1-2, 1993, Pages 119-121

  Farber, Nuri B ^a   Price, Madelon T ^a   Labruyere, Joann ^a   Nemnich, Janice ^a   St Peter, Heidi ^a   Wozniak, David F ^a   Olney, John W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYL SULFOXIDE; DIZOCILPINE; KETAMINE; PHENCYCLIDINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DOSE RESPONSE; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; NERVE CELL DEGENERATION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMAL; CEREBRAL CORTEX; CLOZAPINE; FEMALE; HALOPERIDOL; PHENCYCLIDINE; RATS; RECEPTORS, PHENCYCLIDINE; SUPPORT, U.S. GOV'T, P.H.S.; THIORIDAZINE;

EID: 0027249274     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(93)90265-F     Document Type: Article

References (11)

1. General pharmacology of clozapine
2. Subjective effects of narcotic antagonists cyclazocine and nalorphine on the addiction research center inventory (ARCI)
3. Non-competitive antagonists of excitatory amino acid receptors
4. Novel antipsychotic drugs share high affinity for sigma receptors
5. Effect of thiopentone on emergence reactions to ketamine anaesthesia
6. General Anesthetics
7. Excitatory amino acids and neuropsychiatric disorders
8. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs
9. NMDA antagonist neurotoxicity: Mechanism and prevention
10. Ketamine: an update on the first twenty years of clinical experience
11. 3H]tolyl)guanidine: A selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs